Quarterly report pursuant to Section 13 or 15(d)

Fair Value Considerations (Additional Information) (Details)

v3.22.1
Fair Value Considerations (Additional Information) (Details) - $ / shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted average grant-date fair value of options granted (in Dollars per share) $ 1.77 $ 18.52
Exercise price per (in Dollars per share) 11.50  
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Remaining stock, closing price 5.86  
Weighted average grant-date fair value of options granted (in Dollars per share) 5.86  
Grant date fair value of stock granted $ 0